MasterClass – Outplanning Pricing Uncertainty in Self-Funded Renewals

Dynamic health plan consulting requires moving away from the belief that renewal planning begins with the delivery of the carrier renewal package. It is a critical flaw for brokers to routinely wait for carrier underwriting packages to arrive before determining their strategic next steps. To help employee benefit consultants navigate an increasingly complex market, this MasterClass session recap provides an in-depth analysis of advanced renewal pricing, macroeconomic cost drivers, and actuarial scenario planning.

Presented by James Hechler, FSA, FCA, MAAA, Senior Vice President of Actuarial Services at Benecon, this MasterClass will help to address your uncertainties around self-funded renewals.

The most critical blind spot in modern renewal planning is treating the annual renewal as a transaction. Spreadsheeting multiple carriers and pointing to the lowest upfront fixed cost is not a strategy, it is a temporary bandage that fails to stop underlying issues while introducing new contract risk.

True consulting requires shifting the client conversation away from reactive vendor shopping toward executing a multi-year risk management plan. True renewal planning is dynamic, continuous, and begins just a few months after the previous plan year goes live—long before final underwriting numbers are released.

Advisors must establish an accurate baseline when presenting financial forecasts to client C-suites. Healthcare claim trends are currently running at approximately 10% per year, a significant increase from the stable 7% to 8% baseline seen in the post-ACA, pre-pandemic era.

This 10% annualized trend is driven by specific macroeconomic and clinical factors:

This trend is driven by increased provider operating expenses, as well as hospital and physician-system consolidation. Due to persistent macroeconomic inflation and labor market shortages, clinical staffing labor costs continue to rise, forcing hospitals to renegotiate commercial reimbursement schedules upward.

Plan populations are experiencing rising overall clinical morbidity. With 10,000 Baby Boomers turning 65 every day, the total volume of Medicare-eligible individuals nationally is set to scale upward by 33% by 2030. Medicare reimbursement rates are less than 50% of commercial reimbursement rates. As more enrollment shifts to Medicare, providers will continue to negotiate higher commercial reimbursement rates, shifting costs onto the private sector to offset low public margins.

The rapid commercialization of blockbuster pharmaceuticals represents a primary source of plan volatility.

The Real Cost of GLP-1s: GLP-1 medications are driving a massive financial impact, averaging $30 to $40 Per Employee Per Month (PEPM) across commercial plans. Actuarial charting shows that 2/3 of utilization stems from true medical necessity (e.g., Ozempic for type-2 diabetes management), while 1/3 is driven by lifestyle or weight-loss demand (e.g., Wegovy). The introduction of oral GLP-1 formulations in early 2026 continues to accelerate plan volume. Notably, James Hechler highlighted a recent carrier study tracking weight-loss GLP-1 users over 24 months, which revealed that overall medical claims actually increased, not decreased, due to side-effect management and more frequent clinical interactions.

Provider networks have integrated advanced AI listening tools via tablets and iPads into standard exam rooms. These platforms record client conversations, flag clinical symptoms, and automatically generate optimized charting notes for billing departments. By identifying secondary conditions discussed during a primary visit (e.g., a patient mentioning knee joint pain during a routine diabetes check), the AI tool re-categorizes the event under a highly complex diagnostic code. This increases provider coding intensity, generating higher reimbursement rates from the health plan for the exact same clinical encounter.

To counter these system pressures, advisors must look past fully insured carrier models. Under the Affordable Care Act (ACA), fully insured large group platforms (100+ lives) operate under a mandatory 85% Minimum Loss Ratio (MLR), allowing carriers to permanently retain 15% of every premium dollar for administrative overhead and profit. In the small group market, the MLR drops to 80%, guaranteeing carriers keep 20% of premium revenue. Carriers routinely overshoot these targets, knowing they can hold excess corporate capital interest-free and issue back-end refunds if needed to satisfy the statutory baseline.

Self-funding offers a structurally superior financing platform by capitalizing on the A-T-U-T framework:

• Admin Savings: Capping fixed overhead fees significantly below legacy carrier margins.
• Tax Savings: Reducing state premium taxes by applying the statutory tax rate exclusively to the stop-loss premium layer, rather than the entire claim fund.
• Underwriting Gains: Allowing the employer to retain 100% of plan surpluses directly within corporate reserves, rather than forfeiting health plan efficiency to an insurance carrier.
• Transparency: Gaining line-item insight into where every healthcare dollar is spent to implement targeted cost containment.

Self-funding provides an efficient financing mechanism, but it does not automatically lower claim costs on its own. It serves as a data platform to introduce solutions to manage those costs over the long term. By evaluating the plan performance throughout the year, a prepared consultant can proactively develop renewal strategies to help clients manage their renewal.

• Scenario A: Single-Digit Renewal. Execute minor contribution adjustments, deploy baseline plan design optimization, and introduce entry-level network steerage.
• Scenario B: 10% to 20% Renewal. Implement more significant cost solutions, expand specific clinical point solutions, introduce active pharmacy carve-outs, and deploy targeted facility steerage.
• Scenario C: Over 20% Renewal Emergency. Deploy intensive structural changes—including spousal exclusions, strict spousal surcharges, mandatory leave tracking, biosimilar drug switches, or radical narrow network restructures—while remaining within statutory ACA affordability guidelines.

When an advisor properly prepares an executive team, they eliminate sudden renewal surprises. As James Hechler noted, the ideal outcome of a strategic renewal meeting is when a client’s CFO states, “I don’t like my renewal. I understand it, but I don’t like it.” This realization shows that the employer understands exactly where they stand, accepts the reality of market trends, and is ready to collaborate with their consultant to pull the appropriate operational levers. This is a good sign.